KTTA

Pasithea Therapeutics Corp

Price

$0.52

return (12m)

-28.26%

p/e

-0.75

p/bv

0.32

DIVIDEND YIELD

0.00%

KTTA price

Pasithea Therapeutics Corp

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KTTA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.85%

3 months

-2.82%

1 year

-28.26%

2 years

-87.23%

5 years

-99.04%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals KTTA

Valuation

P/E

-0.75

Sector 7.84

Industry 7.84

P/BV

0.32

Sector 1.84

Industry 1.84

P/Revenue (PSR)

Sector 1.78

Industry 1.78

EV/EBITDA

5.35

Sector -57.74

Industry -57.74

EV/EBIT

5.21

Sector -289.61

Industry -289.61

P/EBITDA

-0.68

Sector -9.38

Industry -9.38

P/EBIT

-0.66

Sector -9.71

Industry -9.71

P/Total Assets

0.31

Sector 0.86

Industry 0.86

P/Net Current Assets

0.34

Sector -2.04

Industry -2.04

P/Working Capital

0.34

Sector -4,847.72

Industry -4,847.72

EPS

-0.66

Sector 0.73

Industry 0.73

BVPS

1.55

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

0.00%

Sector 35.14%

Industry 35.14%

EBITDA Margin

Sector 7.88%

Industry 7.88%

EBIT Margin

Sector -7.02%

Industry -7.02%

Operating Margin

0.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

0.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-42.72%

Sector 2.49%

Industry 2.49%

ROA

-41.17%

Sector -0.64%

Industry -0.64%

ROIC

-526.91%

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

26.25

Sector 1.46

Industry 1.46

Net Debt / EBITDA

8.22

Sector -20.28

Industry -20.28

Net Debt / EBIT

7.99

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

-0.92

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.00

Sector 0.06

Industry 0.06

Equity/Assets

0.96

Sector 0.43

Industry 0.43

Liabilities/Assets

0.04

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

39.14%

Sector -

Industry -

Fundamentals KTTA

DRAG THE FRAME TO SEE MORE DATA

KTTA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pasithea Therapeutics Corp

Pasithea Therapeutics Corp

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

5

Employees

Pasithea Therapeutics Corp (United States) is listed on the Nasdaq and has a market capitalization of $15.93 million, with shareholders equity totaling $49.84 million.

The company employs approximately 5 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Pasithea Therapeutics Corp reported $- in revenue, generating net income of $-21.29 million.

Key financial metrics include a P/E ratio of -0.75, a price-to-book (P/B) ratio of 0.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KTTA.

Market cap

$15.93 million

Net worth

$49.84 million

$49,840,000.00

Assets

$51.71 million

$51,710,000.00

Total Shares Outstanding

32.10 million

32,100,000

Average Daily Trading Volume

$262.72 Thousand

$262,723.56

Sector

Others

Industry

Others

KTTA

KTTA revenue and profits

Financial Results KTTA

DRAG THE FRAME TO SEE MORE DATA

KTTA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$376.90 15,64% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$94.54 39,90% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.82 --51,21% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$308.78 7,28% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$50.71 --9,19% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$90.81 62,23% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$92.85 5,99% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$410.95 34,33% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97